These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1646086)

  • 21. Individual variation in the frequency of HLA class II-specific cytotoxic T lymphocyte precursors.
    Man S; Lechler RI; Batchelor JR; Sharrock CE
    Eur J Immunol; 1990 Apr; 20(4):847-54. PubMed ID: 2112094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
    Burrows SR; Khanna R; Burrows JM; Moss DJ
    J Exp Med; 1994 Apr; 179(4):1155-61. PubMed ID: 7511682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.
    Boon AC; de Mutsert G; Graus YM; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2002 Jan; 76(2):582-90. PubMed ID: 11752149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells.
    Haque T; Taylor C; Wilkie GM; Murad P; Amlot PL; Beath S; McKiernan PJ; Crawford DH
    Transplantation; 2001 Oct; 72(8):1399-402. PubMed ID: 11685111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased frequency of antigen-specific CD8(+) cytotoxic T lymphocytes infiltrating an Epstein-Barr virus-associated gastric carcinoma.
    Kuzushima K; Nakamura S; Nakamura T; Yamamura Y; Yokoyama N; Fujita M; Kiyono T; Tsurumi T
    J Clin Invest; 1999 Jul; 104(2):163-71. PubMed ID: 10411545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.
    Kerr BM; Kienzle N; Burrows JM; Cross S; Silins SL; Buck M; Benson EM; Coupar B; Moss DJ; Sculley TB
    J Virol; 1996 Dec; 70(12):8858-64. PubMed ID: 8971014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.
    Tsuge I; Morishima T; Kimura H; Kuzushima K; Matsuoka H
    J Med Virol; 2001 Jun; 64(2):141-8. PubMed ID: 11360246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of cytotoxic T cell precursor frequencies directed against individual HLA-A and -B alloantigens.
    Zhang L; Li SG; Vandekerckhove B; Termijtelen A; Van Rood JJ; Claas FH
    J Immunol Methods; 1989 Jul; 121(1):39-45. PubMed ID: 2787821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients.
    Mifsud NA; Nguyen TH; Tait BD; Kotsimbos TC
    Transplantation; 2010 Dec; 90(12):1439-49. PubMed ID: 21042237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of individual HLA-A and -B mismatches on the generation of cytotoxic T lymphocyte precursors.
    Zhang L; van Bree S; van Rood JJ; Claas FH
    Transplantation; 1990 Dec; 50(6):1008-10. PubMed ID: 2256142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic T lymphocytes against HLA-B antigens are less naive than cytotoxic T lymphocytes against HLA-A antigens.
    Roelen DL; van Bree SP; van Beelen E; Schanz U; van Rood JJ; Claas FH
    Transplantation; 1994 Feb; 57(3):446-50. PubMed ID: 8108881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parainfluenza type 1 virus-infected cells are killed by both CD8+ and CD4+ cytotoxic T cell precursors.
    Slobod KS; Allan JE
    Clin Exp Immunol; 1993 Sep; 93(3):363-9. PubMed ID: 8396514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.
    Lucas KG; Small TN; Heller G; Dupont B; O'Reilly RJ
    Blood; 1996 Mar; 87(6):2594-603. PubMed ID: 8630428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of different lymphocyte subsets in human anti-viral T cell cultures.
    Gomez A; Bourgault I; Gomard E; Picard F; Levy JP
    Cell Immunol; 1989 Feb; 118(2):312-27. PubMed ID: 2562930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation.
    Mathew JM; Marsh JW; Susskind B; Mohanakumar T
    J Clin Invest; 1993 Mar; 91(3):900-6. PubMed ID: 8450068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ex vivo inducing cultured Epstein-Barr virus specific cytotoxic T lymphocytes and evaluation of their killing effect].
    Chen GH; Gu B; Chen F; Wang Y; Qiao M; Liu HW; Feng YF; Dai LJ; Zhu ZL; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1597-601. PubMed ID: 24370055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice.
    Shultz LD; Saito Y; Najima Y; Tanaka S; Ochi T; Tomizawa M; Doi T; Sone A; Suzuki N; Fujiwara H; Yasukawa M; Ishikawa F
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13022-7. PubMed ID: 20615947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons.
    Geretti AM; Dings ME; van Els CA; van Baalen CA; Wijnholds FJ; Borleffs JC; Osterhaus AD
    J Infect Dis; 1996 Jul; 174(1):34-45. PubMed ID: 8656011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro.
    Gansuvd B; Hagihara M; Munkhbat B; Kanai N; Morita N; Munkhtuvshin N; Chargui J; Kato S; Hotta T; Tsuji K
    Clin Exp Immunol; 2000 Jan; 119(1):107-14. PubMed ID: 10606971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma.
    Chua D; Huang J; Zheng B; Lau SY; Luk W; Kwong DL; Sham JS; Moss D; Yuen KY; Im SW; Ng MH
    Int J Cancer; 2001 Oct; 94(1):73-80. PubMed ID: 11668481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.